Swiss National Bank Trims Holdings in CVS Health Corp (NYSE:CVS)

Swiss National Bank decreased its holdings in CVS Health Corp (NYSE:CVS) by 5.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,273,503 shares of the pharmacy operator’s stock after selling 265,600 shares during the period. Swiss National Bank owned about 0.33% of CVS Health worth $232,863,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. Capital Investment Advisory Services LLC grew its position in shares of CVS Health by 3.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock worth $277,000 after buying an additional 189 shares in the last quarter. Virginia National Bank boosted its position in CVS Health by 4.9% during the first quarter. Virginia National Bank now owns 4,100 shares of the pharmacy operator’s stock valued at $221,000 after purchasing an additional 190 shares in the last quarter. Burke & Herbert Bank & Trust Co. boosted its position in CVS Health by 2.8% during the first quarter. Burke & Herbert Bank & Trust Co. now owns 7,466 shares of the pharmacy operator’s stock valued at $402,000 after purchasing an additional 200 shares in the last quarter. First Command Financial Services Inc. boosted its position in CVS Health by 16.0% during the second quarter. First Command Financial Services Inc. now owns 1,464 shares of the pharmacy operator’s stock valued at $80,000 after purchasing an additional 202 shares in the last quarter. Finally, Hudock Capital Group LLC boosted its position in CVS Health by 54.0% during the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 202 shares in the last quarter. Institutional investors and hedge funds own 77.18% of the company’s stock.

NYSE CVS traded up $1.42 during trading on Friday, hitting $60.26. The company’s stock had a trading volume of 388,643 shares, compared to its average volume of 8,321,043. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64. The company has a market cap of $77.83 billion, a PE ratio of 8.51, a P/E/G ratio of 1.31 and a beta of 0.90. The business’s 50 day simple moving average is $56.32 and its 200-day simple moving average is $56.32. CVS Health Corp has a fifty-two week low of $51.72 and a fifty-two week high of $82.15.



CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.19. The business had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The company’s quarterly revenue was up 35.2% on a year-over-year basis. During the same quarter last year, the company earned $1.69 earnings per share. Analysts expect that CVS Health Corp will post 6.96 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Shareholders of record on Thursday, July 25th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 3.32%. The ex-dividend date of this dividend was Wednesday, July 24th. CVS Health’s dividend payout ratio is presently 28.25%.

A number of brokerages recently weighed in on CVS. Evercore ISI set a $63.00 price objective on CVS Health and gave the company a “buy” rating in a research report on Wednesday, August 7th. Guggenheim began coverage on CVS Health in a research report on Thursday, April 18th. They set a “buy” rating and a $75.00 price objective on the stock. BMO Capital Markets set a $63.00 price objective on CVS Health and gave the company a “hold” rating in a research report on Friday, May 3rd. ValuEngine downgraded CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 2nd. Finally, Raymond James dropped their price objective on CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research report on Thursday, April 18th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $75.14.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: Does a trade war provide a risk to the global economy?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.